Nebenwirkungen · Bimervax
BIMERVAX emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted) · Abschnitt 4.8 · PDF-Seite 6
HOS-151237 · Präparat HOS-100493
Gastrointestinal Diarrhoea Odynophagia disorders Vomiting Abdominal painb Nausea Skin and Pruritus Urticaria subcutaneous Cold sweats tissue disorders Rash Erythema Musculoskeletal Myalgia Arthralgia and connective tissue disorders General disorders Injection Injection site Asthenia Injection site and site pain swelling Chills bruising administration Fatigue Injection site Malaise Injection site site conditions erythema Injection site hypersensitivity Injection site pruritus induration Pyrexia Axillary pain a This term also included events reported as lymphadenitis b This term also included events reported as upper and lower abdominal pain c Based on a single event during clinical trials
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-20T13:15:05Z · SHA-256 9021815ee653b04aa62b8ee1b9ae8cc9cdf72bb8edc2998f5a88fe9d974331b9 · Passage 39e0f65abdea36c54fcc6cc816a953d6d305bc6dc66d4a8b9dfbacd8f6ffde4b · Zeichen 3548–4951 im Abschnitt